MedicaidAdministrativeMedium impact
Provider Bulletin 11-26-2025 DEA Announces Three New Telemedicine Rules IM IE LA SAC SD
Molina Healthcare·CA · Psychiatry, Pain Management, Family Medicine +2 more·Provider Bulletin
We identified it
Jun 19, 2026
Summary
The DEA has announced three new permanent telemedicine rules that allow providers to prescribe controlled substances via telemedicine under specific conditions, including expanded buprenorphine treatment access and new special registration requirements for Schedule II-V medications.
Action Required
Before December 2025: Providers prescribing controlled substances via telemedicine must review new DEA requirements and determine if special registrations are needed. Update telemedicine protocols to ensure compliance with patient evaluation requirements. Contact Molina Provider Relations Representative for guidance on implementation.